Biocon inks deal with Tabuk Pharma to commercialize GLP -1 products in Middle East

Biocon said that it has signed a licensing and supply agreement with Tabuk Pharmaceutical Manufacturing Company to commercialize its GLP-1 products for treating diabetes and chronic weight management, in select countries of the Middle East.